Dr Reddys Laboratories (RDY) Change in Working Capital (2016)
Dr Reddys Laboratories (RDY) recorded quarterly Change in Working Capital of $171.6 million in Q3 2016, up 231616.61% quarter-over-quarter from -$74121.8 in Q1 2016.
Dr Reddys Laboratories (RDY) Change in Working Capital (2016) Analysis & Trends
Dr Reddys Laboratories' Change in Working Capital history runs 1 years deep, the most recent figure standing at $171.6 million for Q3 2016.
- In Q3 2016, Change in Working Capital changed N/A year-over-year to $171.6 million; the TTM figure through Sep 2016 stood at $171.6 million (changed N/A YoY), while the FY2016 annual figure was $163.5 million, changed N/A from the prior year.
- Change in Working Capital was $171.6 million for Q3 2016 at Dr Reddys Laboratories, up from -$74121.8 in the prior quarter.
- In the past five years, Change in Working Capital ranged from a high of $171.6 million in Q3 2016 to a low of -$74121.8 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 215.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 171.60 Mn |
| Sep 30, 2016 | 171.60 Mn |
| Mar 31, 2016 | -74,121.75 |
| Mar 31, 2016 | -74,121.75 |